Credit Suisse’s abrdn Life Sciences Investors HQL Stock Holding History

Credit Suisse’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$192K	–	3929
2021 Q4	$192K	Hold	10,000	–	–	﹤0.01%	4286
2021 Q3	$208K	Hold	10,000	–	–	﹤0.01%	4216
2021 Q2	$10K	Buy	+10,000	New	+$202K	﹤0.01%	4431
2016 Q1	–	Sell	-52,108	Closed	-$1.23M	–	4113
2015 Q4	$1.23M	Buy	52,108 +271	+0.5%	+$6.72K	﹤0.01%	2654
2015 Q3	$1.17M	Buy	51,837 +810	+2%	+$22.7K	﹤0.01%	2692
2015 Q2	$1.44M	Buy	51,027 +934	+2%	+$25.9K	﹤0.01%	2841
2015 Q1	$1.38M	Sell	50,093 -48,206	-49%	-$1.31M	﹤0.01%	2717
2014 Q4	$2.45M	Buy	+98,299	New	+$2.36M	﹤0.01%	2379
2014 Q3	–	Sell	-94,101	Closed	-$1.95M	–	4525
2014 Q2	$1.95M	Buy	94,101 +24,972	+36%	+$524K	﹤0.01%	2739
2014 Q1	$1.5M	Buy	69,129 +1,294	+2%	+$28.8K	﹤0.01%	2758
2013 Q4	$1.39M	Buy	67,835 +1,235	+2%	+$24K	﹤0.01%	2999
2013 Q3	$1.28M	Buy	66,600 +23,130	+53%	+$443K	﹤0.01%	2759
2013 Q2	$777K	Buy	+43,470	New	+$785K	﹤0.01%	2990

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Credit Suisse's HQL Position: Q1 2022 in Review

Credit Suisse sold out of abrdn Life Sciences Investors (HQL) in Q1 2022, closing a stake of 10,000 shares — an estimated $192K sold.

Credit Suisse first reported a position in HQL in Q2 2013 and held it in 13 quarters. The position peaked at $2.45M in Q4 2014. 66 funds tracked by Wall St. Rank hold HQL as of Q1 2022.

Credit Suisse reported no remaining abrdn Life Sciences Investors position as of Q1 2022 after selling out during the quarter.
Credit Suisse sold 10,000 abrdn Life Sciences Investors shares in Q1 2022, an estimated $192K.
Credit Suisse first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 13 quarters.
Credit Suisse's abrdn Life Sciences Investors position peaked at $2.45M in Q4 2014.
66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2022.

Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.